Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
|
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 50 条
  • [41] Recurrent and novel disease-causing F8 variants in boys with severe haemophilia A in Poland
    Janczar, Szymon
    Babol-Pokora, Katarzyna
    Jatczak-Pawlik, Izabela
    Wypyszczak, Kamila
    Klukowska, Anna
    Laguna, Pawel
    Kostrzewska, Magdalena
    Wegner, Olga
    Zielinski, Jaroslaw
    Koltan, Andrzej
    Bobrowska, Halina
    Woznica-Karczmarz, Irena
    Dakowicz, Lucja
    Wlazlowski, Marek
    Ruranska, Iwona
    Dobaczewski, Grzegorz
    Radwanska, Monika
    Karolczyk, Grazyna
    Pietrys, Danuta
    Balwierz, Walentyna
    Szczepanski, Tomasz
    Urasinski, Tomasz
    Ploski, Rafal
    Mlynarski, Wojciech
    HAEMOPHILIA, 2019, 25 (04) : E311 - E314
  • [42] F8 genotype specific inhibitor risks in Argentine patients with severe HA and particular risk estimation of different mutation types
    Rossetti, Liliana
    Radic, Claudia
    Abelleyro, Miguel
    Marchione, Vanina
    Szurkalo, Irupe
    Primiani, Laura
    Neme, Daniela
    Candela, Miguel
    Tezanos Pinto, Miguelde
    Brasi, Carlosde
    HAEMOPHILIA, 2014, 20 : 45 - 45
  • [43] Molecular analysis of F8 in Lebanese haemophilia A patients:: novel mutations and phenotype-genotype correlation
    Khayat, C. Djambas
    Salem, N.
    Chouery, E.
    Corbani, S.
    Moix, I.
    Nicolas, E.
    Morris, M. A.
    de Moerloose, P.
    Megarbane, A.
    HAEMOPHILIA, 2008, 14 (04) : 709 - 716
  • [44] Investigation of a complex rearrangement in the F8 gene to provide carrier diagnosis in a family with severe haemophilia A
    Theophilus, B. D. M.
    Pezeshkpoor, B.
    El-Maarri, O.
    Guilliatt, A. M.
    Motwani, J.
    Oldenburg, J.
    Williams, M. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 44 - 44
  • [45] F8 and HLA-II Haplotypes in the Hispanic Population: Implications for Inhibitor Risk Development in Hispanic Hemophilia A Patients
    Kim, Benjamin
    Sauna, Zuben E.
    Carless, Melanie A.
    Curran, Joanne E.
    Viel, Kevin R.
    Cole, Shelley S.
    Raja, Rajalingam
    Blangero, John
    Howard, Tom E.
    BLOOD, 2012, 120 (21)
  • [46] Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010
    Vezina, C.
    Carcao, M.
    Infante-Rivard, C.
    Lillicrap, D.
    Stain, A. M.
    Paradis, E.
    Teitel, J.
    Rivard, G. E.
    HAEMOPHILIA, 2014, 20 (06) : 771 - 776
  • [47] F8 gene mutation profile in Indian hemophilia A patients: Identification of 23 novel mutations and factor VIII inhibitor risk association
    Pinto, Patricia
    Ghosh, Kanjaksha
    Shetty, Shrimati
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2016, 786 : 27 - 33
  • [48] Treatment related factors and inhibitor development in children with severe haemophilia A
    Maclean, P. S.
    Richards, M.
    Williams, M.
    Collins, P.
    Liesner, R.
    Keeling, D. M.
    Yee, T.
    Will, A. M.
    Young, D.
    Chalmers, E. A.
    HAEMOPHILIA, 2011, 17 (02) : 282 - 287
  • [49] Identification of F8 rearrangements in carrier and non-carrier mothers of haemophilia A patients
    Manderstedt, Eric
    Lind-Hallden, Christina
    Ljung, Rolf
    Astermark, Jan
    Hallden, Christer
    HAEMOPHILIA, 2021, 27 (05) : E654 - E658
  • [50] Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients
    Pinto, P.
    Ghosh, K.
    Shetty, S.
    HAEMOPHILIA, 2012, 18 (05) : 794 - 797